Monday, 15 August 2022

IGBA’s establishes CEO Advisory Committee

15 February 2022 | News

The committee has 13 leading multinational companies from Canada, Europe, India, Israel, Japan and the US

Image credit: www.igbamedicines.org

Image credit: www.igbamedicines.org

The International Generic and Biosimilar medicines Association (IGBA)  has established a CEO Advisory Committee composed of 13 leading multinational companies from Canada, Europe, India, Israel, Japan, and the US.

 

The committee members are:

  • Chirag Patel, President and Co-CEO, Amneal Pharmaceuticals
  • Jeff Watson, President and CEO, Apotex
  • Pankaj Patel, Chairman - Cadila Healthcare
  • Samina Hamied, Executive Vice-Chairperson - Cipla
  • Satish Reddy, Chairman - Dr Reddy's Laboratories
  • Lucas Sigman, CEO, Insud Pharma SL
  • Vinita Gupta, CEO, Lupin
  • Richard Saynor, CEO, Sandoz
  • Peter Goldschmidt, CEO and Chairman Executive Board - STADA Arzneimittel
  • Dilip Shanghvi, Managing Director - Sun Pharmaceutical Industries
  • Kåre Schultz, President and CEO, Teva Pharmaceuticals Industries
  • David Peix, CEO, Towa Pharma International Holdings 
  • Michael Goettler, CEO, Viatris 

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account